Chronic kidney disease (CKD) affects millions worldwide. It is a long-term condition where the kidneys do not work as well as ...

A new genetic study on the causes of chronic kidney disease that combined multiple health measurements has led to a more ...

New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...

Sibeprenlimab targets a protein called A proliferation-inducing ligand (APRIL), and the drug is designed to limit the ...

Early detection and new biomarkers are changing how we manage acute kidney injury—and its link to chronic kidney disease.

The combination of Bayer's mineralocorticoid receptor antagonist (MRA) finerenone and Boehringer Ingelheim and Eli Lilly's ...

Among hospitalized patients with chronic liver disease, acute kidney injury and hepatorenal syndrome represent a growing ...

Discover how common chronic conditions like diabetes and high blood pressure secretly damage kidneys. Learn prevention ...

Do you know someone with kidney disease? The probability is that you do.  An estimated 35.5 million adults in this country — ...

New modelling highlights the potential societal, economic and environmental benefits of early chronic kidney disease (CKD) intervention which could change lives for thousands of Australians.

Kidney disease is an example of the damage that prolonged, incessant heat can do to the body, says Ollie Jay, a heat ...